US2010160175A1PendingUtilityA1
Catalysis of the cis/trans-isomerisation of secondary amide peptide compounds
Est. expiryAug 20, 2021(expired)· nominal 20-yr term from priority
C07K 7/56A61K 38/00
43
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention is based on the finding that the cis/trans isomerisation of secondary amide peptide bonds in oligo- and polypeptides can be catalytically promoted. This catalysis is effected by enzymes which are hereinafter called “secondary amide peptide bond cis/trans isomerases (APIases). It can be assumed that the APIase activity plays a central role in a number of pathophysiological processes. Thus, the invention relates to pharmaceutical compositions comprising substances which inhibit APIase activity.
Claims
exact text as granted — not AI-modified1 . A method for identifying an inhibitor of a secondary amide peptide bond-specific cis/trans isomerase (APIase) comprising steps of:
incubating a secondary amide peptide bond-specific cis/trans isomerase (APIase) with a peptide substrate of the APIase, and a possible inhibitor molecule of the APIase, wherein incubation is performed under conditions which allow the APIase to catalyse cis/trans isomerisation of the peptide substrate; and determining if the possible inhibitor molecule of the APIase inhibits the cis/trans isomerisation of the peptide substrate and provides an inhibitor constant (K i ) of 100 micromolar or less.
2 . The method of claim 1 where, in the step of incubating, the APIase is less than 0.01% of the concentration of the peptide substrate.
3 . The method of claim 1 where the step of determining comprises spectrophotometrically determining isomerisation of the peptide substrate.
4 . The method of claim 3 where the step of determining comprises spectrophotometrically determining isomerisation of the peptide substrate in the range of 222-228 nm.
5 . The method of claim 1 where the step of determining comprises using nuclear magnetic resonance to determine isomerisation of the peptide substrate.
6 . The method of claim 1 where the step of determining comprises using an indirect method which detects a downstream biochemical reaction of APIase activity and that are selected from group consisting of the detection of protein folding, hydrolysis, and isomer-specific chemical reactions.
7 . The method of claim 1 where, in the step of incubating, the peptide substrate comprises Ala-Leu.
8 . The method of claim 1 where, in the step of incubating, the APIase comprises DnaK.
9 . A method for identifying a peptide inhibitor of a secondary amide peptide bond-specific cis/trans isomerase (APIase) comprising steps of:
preparing a composition comprising a library of peptides; adding an APIase to the composition for a corresponding time and under such conditions which are sufficient to provide a peptide bound to the APIase; determining an amino acid sequence of the peptide identified as bound to the APIase; and determining the inhibitor constant of the peptide identified as bound to the APIase, wherein an inhibition constant of 100 micromolar or less shows an inhibitor of this APIase.
10 . The method of claim 9 further comprising a step of synthesizing the peptide identified as bound to the APIase.
11 . The method of claim 9 wherein the library of peptides is formed from all natural amino acids with the exception of cysteine.
12 . The method of claim 9 wherein the library of peptides comprises peptides having 6 amino acids.
13 . The method of claim 9 wherein the APIase comprises DnaK.
14 . The method of claim 1 wherein the APIase is coupled to a matrix.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.